Speak to a
    2.5 iPAAG expert

    Contura | Hydrogels for life
    • OUR Technology
      • Our Science
      • Our Facility
    • Our Therapeutic areas
      • Orthopaedics
      • Animal Health
      • Urinary Incontinence
    • Our Story
      • About Us
      • History
      • Team
    • Contact us
    • Careers

    Category: Arthrosamid

    New study aims to explore further and determine more clearly how a pioneering treatment for knee osteoarthritis works in the NHS

    Posted on 25 September 2023 | by Margot Michaud | Leave a Comment on New study aims to explore further and determine more clearly how a pioneering treatment for knee osteoarthritis works in the NHS

    First clinician in Wales to offer innovative injection to help patients suffering from knee osteoarthritis

    Posted on 1 September 2023 | by Margot Michaud | Leave a Comment on First clinician in Wales to offer innovative injection to help patients suffering from knee osteoarthritis

    Contura Orthopaedics Ltd joins the International Cartilage Regeneration & Joint Preservation Society as its newest industry partner

    Posted on 25 August 2023 | by Margot Michaud | Leave a Comment on Contura Orthopaedics Ltd joins the International Cartilage Regeneration & Joint Preservation Society as its newest industry partner

    First clinic in Scotland to offer innovative injection to help patients suffering from knee osteoarthritis

    Posted on 8 June 2023 | by Margot Michaud | Leave a Comment on First clinic in Scotland to offer innovative injection to help patients suffering from knee osteoarthritis

    BASK-ing-IN-THE-GLORY-OF-SUCCESSFUL-SEMINAR-AT-LEADING-ORTHOPAEDIC-CONFERENCE-WITH-PATIENT-OUTCOMES-AT-ITS-HEART.pdf

    Posted on 7 June 2023 | by Margot Michaud | Leave a Comment on BASK-ing-IN-THE-GLORY-OF-SUCCESSFUL-SEMINAR-AT-LEADING-ORTHOPAEDIC-CONFERENCE-WITH-PATIENT-OUTCOMES-AT-ITS-HEART.pdf

    New 3 year data demonstrates the long-term efficacy of Arthrosamid® (2.5% injectable polyacrylamide hydrogel)

    Posted on 5 April 2023 | by Margot Michaud | Leave a Comment on New 3 year data demonstrates the long-term efficacy of Arthrosamid® (2.5% injectable polyacrylamide hydrogel)

    Olympic great named as new ambassador for medical device innovator Contura Orthopaedics Ltd

    Posted on 5 December 2022 | by Margot Michaud | Leave a Comment on Olympic great named as new ambassador for medical device innovator Contura Orthopaedics Ltd

    Patients gain access to innovative new procedure for treating knee osteoarthritis as HCA UK partners with Contura Orthopaedics

    Posted on 20 October 2022 | by Margot Michaud | Leave a Comment on Patients gain access to innovative new procedure for treating knee osteoarthritis as HCA UK partners with Contura Orthopaedics

    Completion of prospective open label clinical study of Arthrosamid® for knee osteoarthritis

    Posted on 25 January 2021 | by Podymos | Leave a Comment on Completion of prospective open label clinical study of Arthrosamid® for knee osteoarthritis

    Completion of recruitment for a multi-center, randomized, controlled clinical study of Arthrosamid® for knee osteoarthritis.

    Posted on 25 January 2021 | by Podymos | Leave a Comment on Completion of recruitment for a multi-center, randomized, controlled clinical study of Arthrosamid® for knee osteoarthritis.

    Posts navigation

    Older posts

    Recent Posts

    • New study aims to explore further and determine more clearly how a pioneering treatment for knee osteoarthritis works in the NHS
    • First clinician in Wales to offer innovative injection to help patients suffering from knee osteoarthritis
    • Contura Orthopaedics Ltd joins the International Cartilage Regeneration & Joint Preservation Society as its newest industry partner
    • First clinic in Scotland to offer innovative injection to help patients suffering from knee osteoarthritis
    • BASK-ing-IN-THE-GLORY-OF-SUCCESSFUL-SEMINAR-AT-LEADING-ORTHOPAEDIC-CONFERENCE-WITH-PATIENT-OUTCOMES-AT-ITS-HEART.pdf

    Recent Comments

    • A WordPress Commenter on Speciality European Pharma acquires Contura A/S

    Archives

    • September 2023
    • August 2023
    • June 2023
    • April 2023
    • December 2022
    • October 2022
    • November 2021
    • February 2021
    • January 2021
    • February 2020
    • January 2020
    • December 2019
    • October 2019
    • June 2019
    • May 2018
    • January 2018
    • July 2017
    • April 2017
    • February 2017
    • December 2016
    • May 2016
    • September 2015
    • July 2015
    • December 2014
    • May 2013
    • April 2013

    Categories

    • Arthramid Vet
    • Arthrosamid
    • Bulkamid
    • Contura

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    *2.5 iPAAG is an injectable polyacrylamide hydrogel known for its unique
    composition, comprising of 2.5% cross-linked polyacrylamide and 97.5% water.

    Arthrosamid is a registered trademark of Contura International A/S.
    Contura Vet is a registered trademark of Contura Vet Ltd.
    Privacy Notice
    © copyright 2025 Contura International Ltd.

    We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

    I accept My Preferences